Cargando…

Discrepancies in Composition and Biological Effects of Different Formulations of Chondroitin Sulfate

Osteoarthritis is a common, progressive joint disease, and treatments generally aim for symptomatic improvement. However, SYmptomatic Slow-Acting Drugs in Osteoarthritis (SYSADOAs) not only reduce joint pain, but slow structural disease progression. One such agent is chondroitin sulfate—a complex, h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martel-Pelletier, Johanne, Farran, Aina, Montell, Eulàlia, Vergés, Josep, Pelletier, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272499/ https://www.ncbi.nlm.nih.gov/pubmed/25756648 http://dx.doi.org/10.3390/molecules20034277

Ejemplares similares

Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study
por: Tat, Steeve Kwan, et al.
Publicado: (2007)

Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate
por: Lambert, Cécile, et al.
Publicado: (2012)

Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes
por: Calamia, Valentina, et al.
Publicado: (2010)

Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
por: du Souich, Patrick, et al.
Publicado: (2009)

A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine
por: Calamia, Valentina, et al.
Publicado: (2014)

Chondroitin Sulfate Inhibits Monocyte Chemoattractant Protein-1 Release From 3T3-L1 Adipocytes: A New Treatment Opportunity for Obesity-Related Inflammation?
por: Stabler, Thomas V, et al.
Publicado: (2017)

Chondroitin Sulfate Induces Depression of Synaptic Transmission and Modulation of Neuronal Plasticity in Rat Hippocampal Slices
por: Albiñana, Elisa, et al.
Publicado: (2015)

Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties
por: Calamia, Valentina, et al.
Publicado: (2012)

Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study
por: Pelletier, Jean-Pierre, et al.
Publicado: (2016)

Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis?
por: Orlowsky, Eric W, et al.
Publicado: (2014)

Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate
por: Raynauld, Jean-Pierre, et al.
Publicado: (2013)

Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
por: Hochberg, Marc C, et al.
Publicado: (2016)

In vivo effect of opticin deficiency in cartilage in a surgically induced mouse model of osteoarthritis
por: Farrán, Aina, et al.
Publicado: (2018)

The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man
por: Pelletier, Jean-Pierre, et al.
Publicado: (2002)

Is there a mitochondrial DNA haplogroup connection between osteoarthritis and elite athletes? A narrative review
por: Martel-Pelletier, Johanne, et al.
Publicado: (2022)

Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
por: Wildi, Lukas Martin, et al.
Publicado: (2011)

Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow
por: Pelletier, Jean-Pierre, et al.
Publicado: (2006)

A continuous data driven translational model to evaluate effectiveness of population-level health interventions: case study, smoking ban in public places on hospital admissions for acute coronary events
por: Bonakdari, Hossein, et al.
Publicado: (2020)

Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis
por: Martel-Pelletier, Johanne, et al.
Publicado: (2023)

Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
por: Najar, Mehdi, et al.
Publicado: (2020)

Novel insights for improving the therapeutic safety and efficiency of mesenchymal stromal cells
por: Najar, Mehdi, et al.
Publicado: (2020)

Common Biochemical and Magnetic Resonance Imaging Biomarkers of Early Knee Osteoarthritis and of Exercise/Training in Athletes: A Narrative Review
por: Martel-Pelletier, Johanne, et al.
Publicado: (2021)

A Machine Learning Model to Predict Knee Osteoarthritis Cartilage Volume Changes over Time Using Baseline Bone Curvature
por: Bonakdari, Hossein, et al.
Publicado: (2022)

Biological functions of iduronic acid in chondroitin/dermatan sulfate
por: Thelin, Martin A, et al.
Publicado: (2013)

Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice
por: Ustyuzhanina, Nadezhda E., et al.
Publicado: (2021)

Impact of oral osteoarthritis therapy usage among other risk factors on knee replacement: a nested case-control study using the Osteoarthritis Initiative cohort
por: Dorais, Marc, et al.
Publicado: (2018)

Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case–control study
por: Pelletier, Jean-Pierre, et al.
Publicado: (2022)

Risk factors for the long-term incidence and progression of knee osteoarthritis in older adults: role of nonsurgical injury
por: Pelletier, Jean-Pierre, et al.
Publicado: (2023)

A Highly Active Chondroitin Sulfate Lyase ABC for Enzymatic Depolymerization of Chondroitin Sulfate
por: Fan, Xiao-Man, et al.
Publicado: (2022)

Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes
por: Tardif, Ginette, et al.
Publicado: (2009)

Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca(2+) pathways in human osteoarthritis osteoblasts
por: Martineau, Xavier, et al.
Publicado: (2017)

Serum adipokines/related inflammatory factors and ratios as predictors of infrapatellar fat pad volume in osteoarthritis: Applying comprehensive machine learning approaches
por: Bonakdari, Hossein, et al.
Publicado: (2020)

Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis
por: Blanco, Francisco J., et al.
Publicado: (2019)

Implication of microRNA-140 in osteoarthritis
por: Martel-Pelletier, Johanne
Publicado: (2012)

THE OCCURRENCE OF INTRACELLULAR CHONDROITIN SULFATE
por: Thorp, Frank K., et al.
Publicado: (1963)

INTRACELLULAR SYNTHESIS OF CHONDROITIN SULFATE
por: Dziewiatkowski, Dominic D.
Publicado: (1962)

Holothurian Fucosylated Chondroitin Sulfate
por: Pomin, Vitor H.
Publicado: (2014)

Chondroitin Sulfate Safety and Quality
por: Volpi, Nicola
Publicado: (2019)

Chondroitin Sulfate Synthase-2 Is Necessary for Chain Extension of Chondroitin Sulfate but Not Critical for Skeletal Development
por: Ogawa, Hiroyasu, et al.
Publicado: (2012)

Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: 9-year follow-up data from the Osteoarthritis Initiative
por: Pelletier, Jean-Pierre, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e88l4m3p1d3iagspkf6311l7sl